Deavers MT - Search Results

1

Anti-angiogenesis therapy with bevacizumab for patients with ovarian granulosa cell tumors.

Tao X, Sood AK, Deavers MT, Schmeler KM, Nick AM, Coleman RL, Milojevic L, Gershenson DM, Brown J. Tao X, et al. Among authors: deavers mt. Gynecol Oncol. 2009 Sep;114(3):431-6. doi: 10.1016/j.ygyno.2009.04.021. Epub 2009 Jun 13. Gynecol Oncol. 2009. PMID: 19524286 Free PMC article.

2

Induction of epithelial neoplasms in the ovaries of guinea pigs by estrogenic stimulation.

Silva EG, Tornos C, Deavers M, Kaisman K, Gray K, Gershenson D. Silva EG, et al. Gynecol Oncol. 1998 Nov;71(2):240-6. doi: 10.1006/gyno.1998.5153. Gynecol Oncol. 1998. PMID: 9826466

3

Prognostic significance of p53 expression in advanced-stage ovarian serous borderline tumors.

Gershenson DM, Deavers M, Diaz S, Tortolero-Luna G, Miller BE, Bast RC Jr, Mills GB, Silva EG. Gershenson DM, et al. Clin Cancer Res. 1999 Dec;5(12):4053-8. Clin Cancer Res. 1999. PMID: 10632339

4

Paget's disease of the vulva: pathology, pattern of involvement, and prognosis.

Parker LP, Parker JR, Bodurka-Bevers D, Deavers M, Bevers MW, Shen-Gunther J, Gershenson DM. Parker LP, et al. Gynecol Oncol. 2000 Apr;77(1):183-9. doi: 10.1006/gyno.2000.5741. Gynecol Oncol. 2000. PMID: 10739709

5

Non-Hodgkin's lymphoma involving the vagina: a clinicopathologic analysis of 14 patients.

Vang R, Medeiros LJ, Silva EG, Gershenson DM, Deavers M. Vang R, et al. Am J Surg Pathol. 2000 May;24(5):719-25. doi: 10.1097/00000478-200005000-00011. Am J Surg Pathol. 2000. PMID: 10800991

6

Increased expression of fascin, motility associated protein, in cell cultures derived from ovarian cancer and in borderline and carcinomatous ovarian tumors.

Hu W, McCrea PD, Deavers M, Kavanagh JJ, Kudelka AP, Verschraegen CF. Hu W, et al. Clin Exp Metastasis. 2000;18(1):83-8. doi: 10.1023/a:1026596609969. Clin Exp Metastasis. 2000. PMID: 11206843

7

Serous tumors involving extra-abdominal/extra-pelvic sites after the diagnosis of an ovarian serous neoplasm of low malignant potential.

Malpica A, Deavers MT, Gershenson D, Tortolero-Luna G, Silva EG. Malpica A, et al. Among authors: deavers mt. Am J Surg Pathol. 2001 Aug;25(8):988-96. doi: 10.1097/00000478-200108000-00002. Am J Surg Pathol. 2001. PMID: 11474282

8

Second primary or recurrence? Comparative patterns of p53 and K-ras mutations suggest that serous borderline ovarian tumors and subsequent serous carcinomas are unrelated tumors.

Ortiz BH, Ailawadi M, Colitti C, Muto MG, Deavers M, Silva EG, Berkowitz RS, Mok SC, Gershenson DM. Ortiz BH, et al. Cancer Res. 2001 Oct 1;61(19):7264-7. Cancer Res. 2001. PMID: 11585764

9

Ovarian mixed-epithelial carcinomas with a microcystic pattern and signet-ring cells.

Che M, Tornos C, Deavers MT, Malpica A, Gershenson DM, Silva EG. Che M, et al. Among authors: deavers mt. Int J Gynecol Pathol. 2001 Oct;20(4):323-8. doi: 10.1097/00004347-200110000-00002. Int J Gynecol Pathol. 2001. PMID: 11603214

10

Response and survival in patients with progressive or recurrent serous ovarian tumors of low malignant potential.

Crispens MA, Bodurka D, Deavers M, Lu K, Silva EG, Gershenson DM. Crispens MA, et al. Obstet Gynecol. 2002 Jan;99(1):3-10. doi: 10.1016/s0029-7844(01)01649-0. Obstet Gynecol. 2002. PMID: 11777502

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

223 results

Search Page

Filters